Skip to main navigation Skip to search Skip to main content

A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients with Schizophrenia

Project: Research

Project Details

StatusFinished
Effective start/end date01/1/09 → 12/31/13

Funding

  • Otsuka Pharmaceutical Development and Commercialization Inc: $166,052.74